Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Imago Biosciences Inc
(NQ:
IMGO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 10, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Imago Biosciences Inc
< Previous
1
2
3
Next >
7 Healthcare Stocks That Will Be Big Winners in 2023
January 31, 2023
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.
Via
InvestorPlace
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.
Via
InvestorPlace
Looking Into Imago BioSciences's Recent Short Interest
January 04, 2023
Imago BioSciences's (NASDAQ:IMGO) short percent of float has risen 41.79% since its last report. The company recently reported that it has 1.00 million shares sold short, which is 3.97% of all regular...
Via
Benzinga
5 Most Expensive Health Care Stocks You Should Worry About
January 03, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
December 12, 2022
From
Merck & Co., Inc.
Via
Business Wire
Analyst Ratings for Imago BioSciences
November 28, 2022
Via
Benzinga
What 5 Analyst Ratings Have To Say About Imago BioSciences
November 22, 2022
Via
Benzinga
Expert Ratings for Imago BioSciences
November 22, 2022
Via
Benzinga
How Is The Market Feeling About Imago BioSciences?
December 09, 2022
Imago BioSciences's (NASDAQ:IMGO) short percent of float has fallen 3.48% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 13.61% of all regular...
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
December 05, 2022
From
Brodsky & Smith LLC
Via
GlobeNewswire
3 Dow Stocks to Take Seriously in 2023
November 29, 2022
The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
November 28, 2022
Via
Benzinga
IMAGO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Imago BioSciences, Inc. - IMGO
November 22, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Amazon To $119? Here Are 5 Other Price Target Changes For Tuesday
November 22, 2022
Via
Benzinga
TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune
November 22, 2022
Via
AB Newswire
Topics
Death
Economy
Stocks
Exposures
COVID-19
Death
Interest Rates
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
November 22, 2022
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
Via
Benzinga
Nasdaq Down More Than 100 Points; Gold Falls 1%
November 21, 2022
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Monday.
Via
Benzinga
Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session
November 21, 2022
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 21, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
During Monday's session, 50 stocks hit new 52-week highs.
Via
Benzinga
OPEC Rumors, Energy Stocks Drag Wall Street
November 21, 2022
The Dow Jones Industrial Average and Nasdaq Composite are both down over 90 points midday, while the S&P 500 Index sits comfortably below fair value as well.
Via
Talk Markets
Crude Oil Down Over 5%; Imago BioSciences Shares Spike Higher
November 21, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Monday.
Via
Benzinga
Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday
November 21, 2022
U.S. stocks traded lower, with the Dow Jones dropping around 70 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Imago BioSciences (NASDAQ: IMGO) to be Acquired by Merck (NYSE: MRK) for $1.35 Billion
November 21, 2022
Imago BioSciences, Inc. (NASDAQ: IMGO) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development
Via
Spotlight Growth
As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled
November 21, 2022
Markets sent mixed messages to start out Thanksgiving week.
Via
The Motley Fool
Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
November 21, 2022
Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share.
Via
InvestorPlace
Nasdaq Drops Over 50 Points; Bob Iger Returns To Walt Disney
November 21, 2022
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Monday.
Via
Benzinga
Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout
November 21, 2022
Seagen who? Merck is putting its cash to work buying a smaller biotech company.
Via
Investor's Business Daily
IMGO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Imago BioSciences, Inc. Is Fair to Shareholders
November 21, 2022
From
Halper Sadeh LLC
Via
Business Wire
Cancer-Focused Imago BioSciences Shares Soar After Merck Deal
November 21, 2022
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.